Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2018 | 01-2018 | 10-2017 | 07-2017 | 04-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,476 | -844 | -768 | -674 | -6,884 |
| Depreciation Amortization | 360 | 253 | 132 | 42 | 168 |
| Accounts receivable | -1,600 | -669 | -263 | -407 | -986 |
| Accounts payable and accrued liabilities | 301 | 124 | -303 | -120 | -43 |
| Other Working Capital | -1,561 | -1,809 | -1,895 | -1,894 | 1,146 |
| Other Operating Activity | 2,750 | 1,710 | 1,417 | 1,105 | 3,759 |
| Operating Cash Flow | $-1,226 | $-1,235 | $-1,680 | $-1,948 | $-2,840 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,226 | -1,017 | -942 | -910 | -766 |
| Investing Cash Flow | $-1,226 | $-1,017 | $-942 | $-910 | $-766 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -25 | -19 | -13 | -7 | -24 |
| Common Stock Issued | 38 | 38 | N/A | 0 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 4,340 |
| Financing Cash Flow | $13 | $19 | $-13 | $-7 | $4,316 |
| Beginning Cash Position | 3,445 | 3,295 | 3,295 | 3,445 | 2,585 |
| End Cash Position | 1,006 | 1,062 | 660 | 580 | 3,295 |
| Net Cash Flow | $-2,439 | $-2,233 | $-2,635 | $-2,865 | $710 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,226 | -1,235 | -1,680 | -1,948 | -2,840 |
| Capital Expenditure | -1,229 | -1,017 | -942 | -910 | -766 |
| Free Cash Flow | -2,455 | -2,252 | -2,622 | -2,858 | -3,606 |